| 161/318 | US=23-A / Câncer Grandics P. New insights into the role of infection, immunity and apoptosis in the genesis of the cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 161-77. ISBN 978-1-4020-8441-62. |
| 162/318 | US=29 / Patologia Strayer DS, Rubin E. Cell injury. In: Rubin R, Strayer DS. Rubin's pathology: clinicopathologic foundations of medicine. 5th ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 1-35. ISBN 978-0-7817-9516-6. PATOLOGIA; LESAO CELULAR; MORTE CELULAR; APOPTOSE; ENVELHECIMENTO BIOLOGICO |
| 163/318 | US=29-A / Patologia Strayer DS, Rubin E. Cell injury. In: Rubin E, Reisner HM. Essentials of Rubin's pathology. 5th ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 1-17. ISBN 978-0-7817-7324-9. PATOLOGIA; LESAO CELULAR; MORTE CELULAR; APOPTOSE; ENVELHECIMENTO BIOLOGICO |
| 164/318 | US=3 / Química Voet D, Voet JG, Pratt CW. Regulação da expressão gênica. In: ___. Fundamentos de bioquímica: a vida em nível molecular. 2ª ed. Rio de Janeiro: Elsevier, 2008. p. 1010-71. ISBN 85-3631347-4. GENOMA; GENOMICA; DOENCAS DE REPETICOES TRINUCLEOTIDICAS; REGULACAO DA EXPRESSAO GENICA; PROCARIOTOS; EUCARIOTOS; CROMOSSOMO X; CICLO CELULAR; CANCER; APOPTOSE |
| 165/318 | US=33 / Gastro Hamilton JP, Meltzer SJ. The molecular genetics of esophageal cancer. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 167-78. ISBN 978-0-7817-7617-2. CANCER DE ESOFAGO; GENETICA MOLECULAR; CARCINOMA ESOFAGICO FAMILIAL; CARCINOMA ESOFAGICO ESPORADICO; GENETICA; EPIGENETICA; APOPTOSE; ESOFAGO DE BARRETT |
| 166/318 | US=39 / Câncer McCubrey JA, Franklin RA, Bertrand FE, Taylor JR, Chappell WH, Sokolosky ML, Wong EWT, Abrams SL, Stadelman KM, Misaghian N, Ludwing DL, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Terrian DM, Lehmann BD, Steelman LS. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and PI3K/Akt pathways to sensitize cancer cells to therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 81-114. ISBN 978-1-58829-989-5. SEGMENTACAO CASCATAS DE SOBREVIVENCIA; ATIVACAO DE RAS / RAF / MEK / ERK; VIAS PI3K/AKT; SENSIBILIZACAO DAS CELULAS CANCEROSAS; APOPTOSE; CANCER HEMATOPOIETICO |
| 167/318 | US=39 / Câncer Chatterjee D, Sabo E, Resnick MB, Yeung KC, Chin YE. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 159-74. ISBN 978-1-58829-989-5. RKIP; STAT3; QUIMIOTERAPIA; CANCER; APOPTOSE; NF-KB; VIA JAK/STAT; RKIP |
| 168/318 | US=39 / Câncer Bonavida B, Huerta-Yepez S, Vega MI, Spandidos DA, Baritaki S. Nitric oxide-induced immunosensitization to apoptosis by Fas-L and TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 203-10. ISBN 978-1-58829-989-5. |
| 169/318 | US=39 / Câncer Johnson DE. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 243-61. ISBN 978-1-58829-989-5. INIBIDORES BCL-2; AGENTES ANTICANCERIGENOS; APOPTOSE; PEPTIDEOS BH3 |
| 170/318 | US=39 / Câncer Wilson TR, Longley DB, Johnston PG. Therapeutic targeting of apoptosis in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 263-78. ISBN 978-1-58829-989-5. |
| 171/318 | US=3-B / Clín/Médica Morin PJ, Trent JM, Collins FS, Vogelstein B. Genética do câncer. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 492-8. ISBN 85-7726050-8. GENETICA DO CANCER; CANCER; SINDROME DO CANCER FAMILIAR; GENES NAS CELULAS NEOPLASICAS; APOPTOSE; ANGIOGENESE TUMORAL |
| 172/318 | US=3-B / Clín/Médica Fenton RG, Longo DL. Biologia celular e angiogênese. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 498-513. ISBN 85-7726050-8. BIOLOGIA CELULAR DO CANCER; APOPTOSE; CELULA-TRONCO MALIGNAS; ANGIOGENESE TUMORAL; TRATAMENTO ANTIANGIOGENICO |
| 173/318 | US=3-G / Patologia Kumar V, Abbas AK, Fausto N, Mitchell RN. Lesão celular, morte celular e adaptações. In: ___. Robbins patologia básica. 8ª ed. Rio de Janeiro: Elsevier, 2008. p. 1-32. ISBN 85-3522729-1. PATOLOGIA. DEFINICAO; RESPOSTA CELULAR AO ESTRESSE; HIPERTROFIA; HIPERPLASIA; ATROFIA; METAPLASIA; LESAO CELULAR; MORTE CELULAR; LESAO REVERSIVEL; NECROSE; MECANISMOS DA LESAO CELULAR; ISQUEMIA; APOPTOSE; ACUMULO INTRACELULAR; CALCIFICACAO PATOLOGICA; ENVELHECIMENTO CELULAR |
| 174/318 | US=3-G / Patologia Stricker TP, Kumar V. Neoplasia. In: Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins patologia básica. 8ª ed. Rio de Janeiro: Elsevier, 2008. p. 187-243. ISBN 85-3522729-1. NEOPLASIA. NOMENCLATURA; TUMORES BENIGNOS; TUMORES MALIGNOS; DIFERENCIACAO; ANAPLASIA; TAXAS DE CRESCIMENTO TUMORAL; METASTASE; NEOPLASIA. EPIDEMIOLOGIA; CARCINOGENESE; APOPTOSE; ANGIOGENESE; INVASAO DA MATRIZ EXTRACELULAR; INSTABILIDADE GENOMICA; CANCER. ETIOLOGIA; AGENTES CARCINOGENICOS; DEFESA DO HOSPEDEIRO; IMUNIDADE TUMORAL; ANTIGENOS TUMORAIS; EFETORES ANTITUMORAIS; VIGILANCIA IMUNE; NEOPLASIA. ASPECTOS CLINICOS; NEOPLASIA. ESTADIAMENTO; NEOPLASIA. DIAGNOSTICO |
| 175/318 | US=4 / Câncer Garicochea B. Biologia molecular da célula tumoral. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 29-38. ISBN 85-3631168-5. NEOPLASIA; CANCER; BIOLOGIA MOLECULAR; CICLO CELULAR; ONCOGENE; GENES SUPRESSORES DE TUMOR; APOPTOSE; GENE DE REPARO DO DNA; LESAO GENICA |
| 176/318 | US=49-E / Câncer Sionov RV, Spokoini R, Kfir-Erenfeld S, Cohen O, Yefenof E. Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2008. p. 127-248. ISBN 978-0-12-374359-6. SUSCEPTIBILIDADE DE MALIGNIDADES; GLUCOCORTICOIDES; APOPTOSE; RECEPTOR DE GLICOCORTICOIDE; IMUNOSSUPRESSAO |
| 177/318 | US=53 / Biol/Mol Sandberg A, Stone JF. Key mechanisms and pathways. In: ___. The genetics and molecular biology of neural tumors. New Jersey: Humana Press, 2008. p. 431-43. ISBN 978-1-59745-510-7. TUMORES NEURAIS; VIAS MOLECULARES; TP53; RB; WNT; SHH; EGFR; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; TELOMERES; TELOMERASE; EPIGENETICA; CICLO CELULAR; APOPTOSE |
| 178/318 | US=56 / Biol/Mol Mor G, Montagna MK, Alvero AB. Modulation of apoptosis to reverse chemoresistance. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 1-12. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. APOPTOSE; QUIMIORRESISTENCIA; CANCER DE OVARIO; PHENOXODIOL; CASPASE; INIBIDORES DA APOPTOSE; REGULACAO DO XIAP |
| 179/318 | US=56 / Biol/Mol Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 13-21. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. CASPASE-3; APOPTOSE; ESTRESSE GENOTOXICO; IRRADIACAO; PARP-1; CITOMETRIA DE FLUXO; IMUNOHISTOQUIMICA |
| 180/318 | US=56 / Biol/Mol Diaz D, Prieto A, Reyes E, Barcenilla H, Monserrat J, Alvarez-Mon M. Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 23-33. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. CITOMETRIA DE FLUXO; CELULAS CANCEROSAS; APOPTOSE; TAXA APOPTOTICA; INDICE APOPTOTICO; ENUMERACAO DE CELULAS; MEDICAO DA APOPTOSE; MICROESFERAS; ANEXINA V; PERDA DE ANTIGENO; FRAGMENTACAO CELULAR |